Pneumococcal Polysaccharide Protein D-Conjugate Vaccine (Synflorix™; PHiD-CV)

Author： Croxtall Jamie D.   Keating Gillian M.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.11, Iss.5, 2009-10, pp. : 349-357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PHiD-CV dominates PCV-13 in Sweden

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 647, 2012-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

PHiD-CV takes top spot

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 579, 2009-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed): In Older Adults

By Sanford Mark  

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1243-1255

Adis International

Access to resources Recommend Favorite

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]

By Duggan Sean T.  

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 1973-1986

Adis International

Access to resources Recommend Favorite

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]†: Profile Report

By Duggan Sean T.  

Pediatric Drugs, Vol. 14, Iss. 1, 2012-02 ,pp. : 67-69

Adis International

Access to resources Recommend Favorite